Exploring the impact of nasal breathing on physical capacity
The Role of the Nose for Physical Capacity
PHASE4 · Sorlandet Hospital HF · NCT04712799
This study is testing if using a nasal decongestant can help people with nasal blockage and COPD, as well as healthy individuals and athletes, breathe better and improve their physical performance.
Quick facts
| Phase | PHASE4 |
|---|---|
| Study type | Interventional |
| Enrollment | 67 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Sorlandet Hospital HF (other gov) |
| Locations | 1 site (Kristiansand, Agder) |
| Trial ID | NCT04712799 on ClinicalTrials.gov |
What this trial studies
This study investigates the relationship between nasal breathing and physical capacity in individuals with nasal obstruction and COPD, as well as healthy individuals and athletes. It aims to understand how nasal breathing affects daily activities and exercise performance by examining the upper and lower airway interactions. The intervention involves the use of Otrivin, a nasal decongestant, to assess its effects on physical capacity. The findings could lead to evidence-based decisions regarding medical and surgical interventions to improve nasal airflow and overall physical performance.
Who should consider this trial
Good fit: Ideal candidates include individuals with COPD, nasal obstruction, or those interested in enhancing their physical performance.
Not a fit: Patients with other pulmonary diseases or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of nasal breathing's role in improving physical capacity for patients with respiratory conditions and athletes.
How similar studies have performed: While the specific focus on nasal breathing and physical capacity is novel, related studies have shown the importance of airway health in overall physical performance.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: COPD- Exclusion Criteria: * Other pulmonary diseases pregnancy
Where this trial is running
Kristiansand, Agder
- Sørlandet Hospital — Kristiansand, Agder, Norway (RECRUITING)
Study contacts
- Principal investigator: sverre steinsvåg, MD, PhD — senior consultant, professor, investigator
- Study coordinator: sverre steinsvåg, MD, PhD
- Email: sverre.steinsvag@sshf.no
- Phone: 95880342
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Nasal Obstruction, Copd, nose, lungs, physical capacity